KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Deffered Revenue (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Non-Current Deffered Revenue for 8 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 96.31% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 96.31% year-over-year, with the annual reading at $1.0 million for FY2025, 96.31% down from the prior year.
  • Non-Current Deffered Revenue hit $1.0 million in Q4 2025 for Adaptive Biotechnologies, down from $1.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $144.4 million in Q1 2021 to a low of $1.0 million in Q4 2025.
  • Historically, Non-Current Deffered Revenue has averaged $57.1 million across 5 years, with a median of $47.8 million in 2023.
  • Biggest five-year swings in Non-Current Deffered Revenue: dropped 18.08% in 2024 and later tumbled 96.32% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $98.8 million in 2021, then tumbled by 40.66% to $58.6 million in 2022, then fell by 23.56% to $44.8 million in 2023, then plummeted by 39.15% to $27.3 million in 2024, then tumbled by 96.31% to $1.0 million in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for ADPT at $1.0 million in Q4 2025, $1.2 million in Q3 2025, and $20.0 million in Q2 2025.